NEUROPATHIC PAIN MARKET ANALYSIS

Market Challenges And Opportunities

Global Neuropathic Pain Market – Driver

Increasing prevalence of neuropathic pain

The number of people suffering from neuropathy pain is increasing day by day. This results into more demand for diagnostic and treatment technology. Hence, the increasing prevalence of neuropathic pain is expected to boost the growth of market in forecast period. For instance, according to data published by the NIH in PubMed on October, 2021, Neuropathic pain is commonly experienced in older adults. The prevalence of neuropathic pain diagnosis and the use of pain medications among nursing home residents in possible neuropathic pain. The prevalence of neuropathic pain is 14.6% among those with neuropathic pain, 19.7% had diabetic neuropathy, 27.3% had back and neck pain with neuropathic, and 25.1% had hereditary neuropathy.

Global Neuropathic Pain Market – Restraints

Increasing side effects of Drugs

The market is mainly being hindered due to serious breathing problems of seizure and nerve pain medicine this ultimately results in hindering the market’s growth. For instance, in January, 2020, U.S. Food and Drug Administration (FDA) warns serious breathing difficulties may occur in patients using nerve pain medicine. These include use of opioid pain medicines and other drugs that depress the central nervous system and conditions such as chronic obstructive pulmonary disease (COPD) that reduces lung functions.

Global Neuropathic Pain Market – Market Opportunities

Launch of new products by key market players to expand product portfolio